R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Manager - Commercialization Contract Operations

Contract ManagementPosted on Nov 19
ContractRedwood City, CA, USA

About the Job

Requirements

  • A BS/BA degree in a related discipline and 8+ years of relevant experience in contract operations, procurement, purchasing, vendor management, or a related operational role in the pharmaceutical or biotechnology industry.
  • Ability to independently manage complex contracting workflows, resolve ambiguous operational issues, and exercise sound judgment on escalation and stakeholder alignment.
  • Experience leading cross-functional process or system improvements from issue identification through implementation and adoption.
  • Ability to influence business partners and management without direct authority, communicate recommendations, and gain alignment on competing priorities.
  • Ability to build effective partnerships with business owners and colleagues in Legal, Finance, and Procurement in a fast-paced, matrixed environment.
  • Strong organizational skills, attention to detail, and ability to manage concurrent requests and communicate priorities, dependencies, and timelines.
  • Excellent written and verbal communication skills, sound judgment, and a commitment to collaboration, integrity, and corporate values.
  • Proficiency in Microsoft Excel, PowerPoint, Word, and Teams, with experience using contract management systems and operational tracking tools such as Smartsheet.

Responsibilities

  • Manage a complex portfolio of SOWs, CDAs, and MSAs through intake, review, approvals, signature routing, and purchase order follow-through, coordinating interdependent requirements across business owners and functional partners.
  • Ensure assigned requests follow established contracting policies and approval requirements; coordinate resolution of complex operational exceptions with the appropriate Legal, Compliance, Finance, or Procurement partner.
  • Develop and apply contracting prioritization approaches with team leadership and functional partners; recommend tradeoffs and escalate unresolved capacity, timing, or approval constraints.
  • Oversee lifecycle coordination for assigned contracts, including renewals, amendments, and terminations; anticipate dependencies and initiate timely action with business owners.
  • Serve as an operational escalation resource for complex contracting and payment inquiries within assigned scope; align stakeholders on solutions and present recommendations to leadership when decisions exceed delegated authority.
  • Maintain accurate contract records and operational trackers; identify recurring bottlenecks and use available operational data to recommend improvements and inform planning.
  • Lead defined cross-functional improvements to contracting workflows and systems, including assessing issues, recommending solutions, coordinating implementation, and evaluating adoption and results.
  • Develop and improve process guidance and training materials; guide business owners and mentor colleagues on complex operational issues and effective contracting practices.
  • Partner with cross-functional operations colleagues on evolving business needs, including designated ex-U.S. contracting workflows, and recommend practical adaptations within established policies.

Desired Qualifications

  • Experience supporting Commercial or Medical Affairs contracting during launch preparation or organizational growth.
  • Experience improving contract-to-purchase-order workflows, vendor management approaches, implementing contract lifecycle systems, or developing operational guidance and training.
  • Experience mentoring colleagues and sharing expertise on complex operational processes.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs